How big is the 3D bioprinting market?

The global 3D bioprinting market size was estimated at USD 3.07 billion in 2025 and is expected to reach USD 3.49 billion in 2026.

What is the 3D bioprinting market growth?

The global 3D bioprinting market is projected to grow at a CAGR of 9.71% from 2026 to 2033 to reach USD 6.67 billion by 2033.

Which segment accounted for the largest 3D bioprinting market share?

Based on technology, inkjet-based segment dominated the 3D bioprinting market in 2025 due to its high precision, cost-effectiveness, and ability to deposit living cells with minimal material wastage.

Who are the key players in the 3D bioprinting market?

Key companies in the global 3D bioprinting market include Organovo Holdings, Inc., CELLINK, 3D Systems, Inc., Desktop Metal, Inc. (Nano Dimension Ltd.), Aspect Biosystems Ltd., regenHU, CYFUSE, CollPlant are some of the major players in the 3D bioprinting market

What are the factors driving the 3D bioprinting market?

The growth of 3D bioprinting is driven by the increasing demand for advanced tissue-engineering and regenerative-medicine solutions, particularly for organ transplantation and personalized treatments. Rising investments in research, along with technological advancements in biomaterials and printing techniques, are accelerating innovation in this field. In addition, the need for more accurate drug testing models and reduced reliance on animal testing is further supporting market expansion.